Business
UK must alter approval regime so thousands more patients benefit from future cell and gene therapies
A war of words over a benchmark that claims Eli Lilly has zero (out of ten) respect for human rights
Business
UK must alter approval regime so thousands more patients benefit from future cell and gene therapies
A war of words over a benchmark that claims Eli Lilly has zero (out of ten) respect for human rights